The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

Context: Endothelial microparticles (EMPs) are novel, surrogate biomarkers of endothelial function and have been shown to be elevated in women with polycystic ovary syndrome (PCOS). It remains poorly understood how pharmacological options for managing PCOS affect EMP levels. Objective: To characte...

Full description

Bibliographic Details
Main Authors: Zeeshan Javed, Maria Papageorgiou, Leigh A Madden, Alan S Rigby, Eric S Kilpatrick, Stephen L Atkin, Thozhukat Sathyapalan
Format: Article
Language:English
Published: Bioscientifica 2020-06-01
Series:Endocrine Connections
Subjects:
endothelial microparticles
polycystic ovary syndrome
sglt2 inhibitors
empagliflozin
metformin
Online Access:https://ec.bioscientifica.com/view/journals/ec/9/6/EC-20-0173.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/9/6/EC-20-0173.xml

Similar Items